
Berenberg new coverage Halozyme Buy
A Berenberg analyst initiated new coverage Halozyme (NASDAQ: HALO) Buy rating and a price target of $58.00. Prior to this rating, Halozyme had 6 buy ratings, 2 hold ratings, and 1 sell...
A Berenberg analyst initiated new coverage Halozyme (NASDAQ: HALO) Buy rating and a price target of $58.00. Prior to this rating, Halozyme had 6 buy ratings, 2 hold ratings, and 1 sell...
By Davit Kirakosyan Investing.com -- Here is your daily Pro Recap of the biggest analyst cuts you may have missed on InvestingPro since yesterday. Start your free 7-day trial to get this...
HALO has risen by 91.21% in the last 24 hours and 87.31% in the past seven days.
Halozyme (NASDAQ:HALO) Therapeutics, Inc. (HALO) ("Halozyme") today provides an update on a decision by the Opposition Division of the European Patent Office ("EPO") regarding one of the...
Halozyme Therapeutics (NASDAQ:HALO) reported Q4 EPS of $0.48, $0.18 better than the analyst estimate of $0.30. Revenue for the quarter came in at $181 million versus the consensus...
Investing.com - Halozyme (NASDAQ: HALO) reported fourth quarter EPS of $0.48, $0.18 better than the analyst estimate of $0.30. Revenue for the quarter came in at $181M versus the consensus...
IRVINE, Calif. and INDIAN WELLS, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation...
Investing.com - Halozyme reported on Tuesday third quarter {{erl-16236||earnings that beat analysts' forecasts and revenue that topped expectations. Halozyme announced earnings per share...
Halozyme Therapeutics (HALO) reported Q3 EPS of $0.74, $0.42 better than the analyst estimate of $0.32. Revenue for the quarter came in at $209 million versus the consensus estimate of...
CarLotz, Inc. (LOTZ) +29%; Shift (Nasdaq: SFT) announced today it has entered into a definitive agreement to merge with CarLotz a leading used vehicle consignment business, in a...
Halozyme Therapeutics (NASDAQ:HALO) reported Q2 EPS of $0.53, $0.06 better than the analyst estimate of $0.47. Revenue for the quarter came in at $152.4 million versus the consensus...
Investing.com Staff - Magic Empire Global Ltd (NASDAQ:MEGL) +30%; shares declined 89% intraday. The Trade Desk Inc (NASDAQ:TTD) +16%; {{erl-989534||reported Q2 EPS of $0.20, in-line with...
By Sam Boughedda Investing.com -- Halozyme Therapeutics Inc (NASDAQ:HALO) will acquire Antares Pharma Inc (NASDAQ:ATRS) for approximately $960 million, the companies revealed...
By Sam Boughedda Investing.com -- U.S. indices are trading positively Wednesday, with the Nasdaq the biggest mover around lunchtime at +1.45%. Here are the midday movers on Wednesday, April...
Pre-Open Stock Movers: Antares Pharma , Inc. (NASDAQ:ATRS) 49% HIGHER; Halozyme (NASDAQ:HALO) Therapeutics, Inc. (HALO) agreed to acquire the company for $5.60 per share in cash, or $960...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, April 13th. Please refresh for updates. JPMorgan Chase (NYSE:JPM) stock fell 3% after the investment bank...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.